Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Volarević S[au]:

Ribosome biogenesis in cancer: new players and therapeutic avenues. Pelletier J et al. Nat Rev Cancer. (2018)

The relationship between the nucleolus and cancer: Current evidence and emerging paradigms. Orsolic I et al. Semin Cancer Biol. (2016)

Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis. Lindström MS et al. Oncogene. (2018)

Search results

Items: 35

1.

Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis.

Lindström MS, Jurada D, Bursac S, Orsolic I, Bartek J, Volarevic S.

Oncogene. 2018 May;37(18):2351-2366. doi: 10.1038/s41388-017-0121-z. Epub 2018 Feb 12. Review.

2.

Corrigendum: Ribosome biogenesis in cancer: new players and therapeutic avenues.

Pelletier J, Thomas G, Volarević S.

Nat Rev Cancer. 2018 Jan 25;18(2):134. doi: 10.1038/nrc.2018.3.

PMID:
29368746
3.

New insights into HEATR1 functions.

Bursać S, Jurada D, Volarević S.

Cell Cycle. 2018;17(2):143-144. doi: 10.1080/15384101.2017.1411325. Epub 2018 Jan 2. No abstract available.

4.

Ribosome biogenesis in cancer: new players and therapeutic avenues.

Pelletier J, Thomas G, Volarević S.

Nat Rev Cancer. 2018 Jan;18(1):51-63. doi: 10.1038/nrc.2017.104. Epub 2017 Dec 1. Review. Erratum in: Nat Rev Cancer. 2018 Jan 25;18(2):134.

PMID:
29192214
5.

Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

Bublik DR, Bursać S, Sheffer M, Oršolić I, Shalit T, Tarcic O, Kotler E, Mouhadeb O, Hoffman Y, Fuchs G, Levin Y, Volarević S, Oren M.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E496-E505. doi: 10.1073/pnas.1614876114. Epub 2016 Dec 19.

6.

The relationship between the nucleolus and cancer: Current evidence and emerging paradigms.

Orsolic I, Jurada D, Pullen N, Oren M, Eliopoulos AG, Volarevic S.

Semin Cancer Biol. 2016 Jun;37-38:36-50. doi: 10.1016/j.semcancer.2015.12.004. Epub 2015 Dec 23. Review.

PMID:
26721423
7.

TPL2-NPM-p53 pathway monitors nucleolar stress.

Eliopoulos AG, Volarevic S.

Oncoscience. 2015 Oct 5;2(11):892-3. eCollection 2015. No abstract available.

8.

Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice.

Pauk M, Grgurevic L, Brkljacic J, Kufner V, Bordukalo-Niksic T, Grabusic K, Razdorov G, Rogic D, Zuvic M, Oppermann H, Babitt JL, Lin HY, Volarevic S, Vukicevic S.

Int Orthop. 2015 Jan;39(1):161-72. doi: 10.1007/s00264-014-2550-4. Epub 2014 Oct 11.

PMID:
25300398
9.

Physical and functional interaction of the TPL2 kinase with nucleophosmin.

Kanellis DC, Bursac S, Tsichlis PN, Volarevic S, Eliopoulos AG.

Oncogene. 2015 May 7;34(19):2516-26. doi: 10.1038/onc.2014.183. Epub 2014 Jul 7.

PMID:
24998852
10.

p53 and ribosome biogenesis stress: the essentials.

Golomb L, Volarevic S, Oren M.

FEBS Lett. 2014 Aug 19;588(16):2571-9. doi: 10.1016/j.febslet.2014.04.014. Epub 2014 Apr 18. Review.

11.

Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.

Bursac S, Brdovcak MC, Donati G, Volarevic S.

Biochim Biophys Acta. 2014 Jun;1842(6):817-30. doi: 10.1016/j.bbadis.2013.08.014. Epub 2013 Oct 26. Review.

12.

Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.

Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M, Dereli-Oz A, Kocylowski M, Pateras IS, Evangelou K, Kotsinas A, Orsolic I, Bursac S, Cokaric-Brdovcak M, Zoumpourlis V, Kletsas D, Papafotiou G, Klinakis A, Volarevic S, Gu W, Bartek J, Halazonetis TD, Gorgoulis VG.

Nat Cell Biol. 2013 Aug;15(8):967-77. doi: 10.1038/ncb2795. Epub 2013 Jul 14. Erratum in: Nat Cell Biol. 2013 Oct;15(10):1260.

PMID:
23851489
13.

Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.

Bursać S, Brdovčak MC, Pfannkuchen M, Orsolić I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabušić K, Vukelić I, Filić V, Oren M, Prives C, Volarevic S.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20467-72. doi: 10.1073/pnas.1218535109. Epub 2012 Nov 20.

14.

Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.

Golomb L, Bublik DR, Wilder S, Nevo R, Kiss V, Grabusic K, Volarevic S, Oren M.

Mol Cell. 2012 Jan 27;45(2):222-32. doi: 10.1016/j.molcel.2011.11.022. Erratum in: Mol Cell. 2012 Jul 13;47(1):150.

15.

Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins.

Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, Trougakos IP, Kolettas E, Georgakilas AG, Volarevic S, Eliopoulos AG, Zannis-Hadjopoulos M, Moustakas A, Gorgoulis VG.

J Cell Biol. 2011 Dec 26;195(7):1123-40. doi: 10.1083/jcb.201108121.

16.

Natural killer T cells in pulmonary disorders.

Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P.

Respir Med. 2011 Oct;105 Suppl 1:S20-5. doi: 10.1016/S0954-6111(11)70006-3. Review.

17.

The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.

Donati G, Bertoni S, Brighenti E, Vici M, Treré D, Volarevic S, Montanaro L, Derenzini M.

Oncogene. 2011 Jul 21;30(29):3274-88. doi: 10.1038/onc.2011.48. Epub 2011 Mar 14.

PMID:
21399665
18.

PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles.

Reddy P, Adhikari D, Zheng W, Liang S, Hämäläinen T, Tohonen V, Ogawa W, Noda T, Volarevic S, Huhtaniemi I, Liu K.

Hum Mol Genet. 2009 Aug 1;18(15):2813-24. doi: 10.1093/hmg/ddp217. Epub 2009 May 7.

PMID:
19423553
19.

The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival.

Barkić M, Crnomarković S, Grabusić K, Bogetić I, Panić L, Tamarut S, Cokarić M, Jerić I, Vidak S, Volarević S.

Mol Cell Biol. 2009 May;29(10):2489-504. doi: 10.1128/MCB.01588-08. Epub 2009 Mar 9.

20.

S6-haploinsufficiency activates the p53 tumor suppressor.

Panić L, Montagne J, Cokarić M, Volarević S.

Cell Cycle. 2007 Jan 1;6(1):20-4. Epub 2007 Jan 29. Review.

PMID:
17245121
21.

Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation.

Panić L, Tamarut S, Sticker-Jantscheff M, Barkić M, Solter D, Uzelac M, Grabusić K, Volarević S.

Mol Cell Biol. 2006 Dec;26(23):8880-91. Epub 2006 Sep 25.

22.

Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response.

Sulic S, Panic L, Barkic M, Mercep M, Uzelac M, Volarevic S.

Genes Dev. 2005 Dec 15;19(24):3070-82.

23.

Deregulation of cell growth and malignant transformation.

Sulić S, Panić L, Dikić I, Volarević S.

Croat Med J. 2005 Aug;46(4):622-38. Review.

24.

Compartmentalization of growth factor receptor signalling.

Hoeller D, Volarevic S, Dikic I.

Curr Opin Cell Biol. 2005 Apr;17(2):107-11. Review.

PMID:
15780584
25.

CD45 is required for CD40-induced inhibition of DNA synthesis and regulation of c-Jun NH2-terminal kinase and p38 in BAL-17 B cells.

Arimura Y, Ogimoto M, Mitomo K, Katagiri T, Yamamoto K, Volarevic S, Mizuno K, Yakura H.

J Biol Chem. 2001 Mar 16;276(11):8550-6. Epub 2000 Dec 15.

26.

Role of S6 phosphorylation and S6 kinase in cell growth.

Volarević S, Thomas G.

Prog Nucleic Acid Res Mol Biol. 2001;65:101-27. Review.

PMID:
11008486
27.

Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6.

Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E, Grompe M, Kozma SC, Thomas G.

Science. 2000 Jun 16;288(5473):2045-7.

28.

Manipulating mammalian genome by gene targeting.

Volarević S, Pende M, Pullen N.

Croat Med J. 1999 Sep;40(3):368-74. Review.

30.

Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4.

Moriggl R, Kristofic C, Kinzel B, Volarevic S, Groner B, Brinkmann V.

J Immunol. 1998 Apr 1;160(7):3385-92.

31.

Evidence for different mechanisms of growth inhibition of T-cell lymphoma by phorbol esters and concanavalin A.

Desrivières S, Volarević S, Merćep L, Ferrari S.

J Biol Chem. 1997 Jan 24;272(4):2470-6.

32.

Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains.

Volarević S, Niklinska BB, Burns CM, June CH, Weissman AM, Ashwell JD.

Science. 1993 Apr 23;260(5107):541-4.

PMID:
8475386
33.

The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations.

Volarević S, Niklinska BB, Burns CM, Yamada H, June CH, Dumont FJ, Ashwell JD.

J Exp Med. 1992 Sep 1;176(3):835-44.

34.

Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase.

Volarević S, Burns CM, Sussman JJ, Ashwell JD.

Proc Natl Acad Sci U S A. 1990 Sep;87(18):7085-9.

35.

[The effect of physical exercise on lung diffusing capacity in patients with chronic obstructive lung disease].

Volarević S, Marusić M, Tocilj J, Dujić Z.

Plucne Bolesti. 1989 Jan-Jun;41(1-2):42-5. Croatian.

PMID:
2798571

Supplemental Content

Loading ...
Support Center